Zacks Investment Research
18 Mar 2026, 23:45 UTC · 34w ago
MARKER THERAPEUTICS, INC. (MRKR) Reports Q4 Loss, Tops Revenue Estimates
Verdict
Headline takes no side. We score MRKR +0.60 — strongly bullish.
- Expected · MRKR
+0.60strongly bullish
−1 bearish0bullish +1More positive than 78% of ticker scores this week
- Actual
Scored by the NIS engine · methodology.

Search tags



